Binary and quaternary mixtures of perfluoroalkyl substances (PFAS) differentially affect the immune response to influenza A virus infection

References

• Agency for Toxic Substances and Disease Registry [ATSDR]. 2021. Toxicological profile for perfluoroalkyls. Atlanta (GA): Agency for Toxic Substances and Disease Registry.
   Google Scholar
• Antoniou E, Colnot T, Zeegers M, Dekant W. 2022. Immunomodulation and exposure to per- and polyfluoroalkyl substances: An overview of the current evidence from animal and human studies. Arch Toxicol. 96(8):2261–2285. doi: 10.1007/s00204-022-03303-4.
   PubMed Web of Science ®Google Scholar
• Barrett T, Inglis S. 1985. Growth, purification, and titration of influenza viruses. In: Mahy B, editor. Virology: A practical approach. Washington (DC): IRL Press. p. 119–150.
   Google Scholar
• Boule L, Burke C, Jin G, Lawrence B. 2018. Aryl hydrocarbon receptor signaling modulates antiviral immune responses: Ligand metabolism rather than chemical source is the stronger predictor of outcome. Sci Rep. 8(1):1826. doi: 10.1038/s41598-018-20197-4.
   PubMedGoogle Scholar
• Boule L, Winans B, Lawrence B. 2014. Effects of developmental activation of the Ahr on CD4+ T-cell responses to influenza virus infection in adult mice. Environ Health Perspect. 122(11):1201–1208. doi: 10.1289/ehp.1408110.
   PubMed Web of Science ®Google Scholar
• Bulka C, Avula V, Fry R. 2021. Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: Recent findings from NHANES 1999-2016. Environ Pollut. 275:116619. doi: 10.1016/j.envpol.2021.116619.
   PubMed Web of Science ®Google Scholar
• Calafat A, Kato K, Hubbard K, Jia T, Botelho J, Wong L. 2019. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey. Environ Int. 131:105048. doi: 10.1016/j.envint.2019.105048.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control [CDC]. 2019, January. Fourth national report on human exposure to environmental chemicals: Updated tables. Vol. 1. Atlanta: Centers for Disease Control and Prevention.
   Google Scholar
• Chang E, Adami H, Boffetta P, Wedner H, Mandel J. 2016. A critical review of perfluoroocta-noate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Crit Rev Toxicol. 46(4):279–331. doi: 10.3109/10408444.2015.1122573.
   PubMed Web of Science ®Google Scholar
• Cousins IT, DeWitt JC, Glüge J, Goldenman G, Herzke D, Lohmann R, Miller M, Ng CA, Scheringer M, Vierke L, et al. 2020. Strategies for grouping per- and polyfluoroalkyl substances (PFAS) to protect human and environmental health. Environ Sci Process Impacts. 22(7):1444–1460. doi: 10.1039/d0em00147c.
   PubMed Web of Science ®Google Scholar
• De Silva AO, Armitage JM, Bruton TA, Dassuncao C, Heiger-Bernays W, Hu XC, Kärrman A, Kelly B, Ng C, Robuck A, et al. 2021. PFAS exposure pathways for humans and wildlife: A synthesis of current knowledge and key gaps in understanding. Environ Toxicol Chem. 40(3):631–657. doi: 10.1002/etc.4935.
   PubMed Web of Science ®Google Scholar
• DeWitt J, Blossom S, Schaider L. 2019. Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: Epidemiological and toxicological evidence. J Expo Sci Environ Epidemiol. 29(2):148–156. doi: 10.1038/s41370-018-0097-y.
   PubMed Web of Science ®Google Scholar
• DeWitt J, Williams W, Creech N, Luebke R. 2016. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting. J Immunotoxicol. 13(1):38–45. doi: 10.3109/1547691X.2014.996682.
   PubMed Web of Science ®Google Scholar
• Dewitt J, Copeland C, Strynar M, Luebke R. 2008. Perfluorooctanoic acid-induced immuno-modulation in adult C57Bl/6J or C57Bl/6N female mice. Environ Health Perspect. 116(5):644–650. doi: 10.1289/ehp.10896.
   PubMed Web of Science ®Google Scholar
• Dong G, Zhang Y, Zheng L, Liu W, Jin Y, He Q. 2009. Chronic effects of perfluorooctanesulfo-nate exposure on immunotoxicity in adult male C57Bl/6 mice. Arch Toxicol. 83(9):805–815. doi: 10.1007/s00204-009-0424-0.
   PubMed Web of Science ®Google Scholar
• Ehrlich V, Bil W, Vandebriel R, Granum B, Luijten M, Lindeman B, Grandjean P, Kaiser A, Hauzenberger I, Hartmann C, et al. 2023. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS). Environ Health. 22(1):19. doi: 10.1186/s12940-022-00958-5.
   PubMed Web of Science ®Google Scholar
• European Food Safety Authority [EFSA]. 2020. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 18(9):e06223.
   PubMed Web of Science ®Google Scholar
• Evans N, Conley J, Cardon M, Hartig P, Medlock-Kakaley E, Gray L. Jr. 2022. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR)-α, PPAR-γ, and estrogen receptor assays. Toxicol Appl Pharmacol. 449:116136. doi: 10.1016/j.taap.2022.116136.
   PubMed Web of Science ®Google Scholar
• Fair P, Driscoll E, Mollenhauer M, Bradshaw S, Yun S, Kannan K, Bossart G, Keil D, Peden-Adams M. 2011. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice. J Immunotoxicol. 8(1):17–29. doi: 10.3109/1547691X.2010.527868.
   PubMed Web of Science ®Google Scholar
• Feingold B, Vegosen L, Davis M, Leibler J, Peterson A, Silbergeld E. 2010. A niche for infectious disease in environmental health: Re-thinking the toxicological paradigm. Environ Health Perspect. 118(8):1165–1172. doi: 10.1289/ehp.0901866.
   PubMed Web of Science ®Google Scholar
• Fenton S, Ducatman A, Boobis A, DeWitt J, Lau C, Ng C, Smith J, Roberts S. 2021. Per- and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research. Environ Toxicol Chem. 40(3):606–630. doi: 10.1002/etc.4890.
   PubMed Web of Science ®Google Scholar
• Franchini A, Lawrence B. 2018. Environmental exposures are hidden modifiers of anti-viral immunity. Curr Opin Toxicol. 10:54–59. doi: 10.1016/j.cotox.2018.01.004.
   PubMedGoogle Scholar
• Glüge J, Scheringer M, Cousins IT, DeWitt JC, Goldenman G, Herzke D, Lohmann R, Ng CA, Trier X, Wang Z. 2020. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts. 22(12):2345–2373. doi: 10.1039/d0em00291g.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Timmermann CAG, Kruse M, Nielsen F, Vinholt PJ, Boding L, Heilmann C, Mølbak K. 2020. Severity of COIVD-19 at elevated exposure to perfluorinated alkylates. PLoS One. 15(12):e0244815. doi: 10.1371/journal.pone.0244815.
   PubMed Web of Science ®Google Scholar
• Guelfo J, Adamson D. 2018. Evaluation of a national data set for insights into sources, composition, and concentrations of per- and polyfluoroalkyl substances (PFAS) in U.S. drinking water. Environ Pollut. 236:505–513. doi: 10.1016/j.envpol.2018.01.066.
   PubMed Web of Science ®Google Scholar
• Houser C, Lawrence B. 2022. The aryl hydrocarbon receptor modulates T-follicular helper cell responses to influenza virus infection in mice. J Immunol. 208(10):2319–2330. doi: 10.4049/jimmunol.2100936.
   PubMed Web of Science ®Google Scholar
• Ji J, Song L, Wang J, Yang Z, Yan H, Li T, Yu L, Jian L, Jiang F, Li J, et al. 2021. Association between urinary per- and poly-fluoroalkyl substances and COVID-19 susceptibility. Environ Int. 153:106524.,. doi: 10.1016/j.envint.2021.106524.
   PubMed Web of Science ®Google Scholar
• Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol. 45(19):8037–8045. doi: 10.1021/es1043613.
   PubMed Web of Science ®Google Scholar
• Kohlmeier J, Woodland D. 2009. Immunity to respiratory viruses. Annu Rev Immunol. 27(1):61–82. doi: 10.1146/annurev.immunol.021908.132625.
   PubMedGoogle Scholar
• La Gruta N, Turner S. 2014. T-Cell-mediated immunity to influenza: Mechanisms of viral control. Trends Immunol. 35(8):396–402. doi: 10.1016/j.it.2014.06.004.
   PubMed Web of Science ®Google Scholar
• Lam J, Baumgarth N. 2019. The multifaceted B-cell response to influenza virus. J Immunol. 202(2):351–359. doi: 10.4049/jimmunol.1801208.
   PubMed Web of Science ®Google Scholar
• Lawrence B, Roberts A, Neumiller J, Cundiff J, Woodland D. 2006. Aryl hydrocarbon receptor activation impairs the priming but not the recall of influenza virus-specific CD8+ T-cells in the lung. J Immunol. 177(9):5819–5828. doi: 10.4049/jimmunol.177.9.5819.
   PubMed Web of Science ®Google Scholar
• Li Y, Andersson A, Xu Y, Pineda D, Nilsson CA, Lindh C, Jakobsson K, Fletcher T. 2022. Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure-a study in Ronneby, Sweden. Environ Int. 163:107198. doi: 10.1016/j.envint.2022.107198.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang L, Zhang Y, Guan S, Gong X, Wang X. 2019. Maternal exposure to perfluoro-octanoic acid (PFOA) causes liver toxicity through PPARα pathway and lowered histone acetylation in female offspring mice. Environ Sci Pollut Res Int. 26(18):18866–18875. doi: 10.1007/s11356-019-05258-z.
   PubMed Web of Science ®Google Scholar
• Maddalon A, Pierzchalski A, Kretschmer T, Bauer M, Zenclussen AC, Marinovich M, Corsini E, Herberth G. 2023. Mixtures of per- and poly-fluoroalkyl substances (PFAS) reduce the in vitro activation of human T-cells and basophils. Chemosphere. 336:139204. doi: 10.1016/j.chemosphere.2023.139204.
   PubMedGoogle Scholar
• McDonough C, Ward C, Hu Q, Vance S, Higgins C, DeWitt J. 2020. Immunotoxicity of an electrochemically-fluorinated aqueous film-forming foam. Toxicol Sci. 178(1):104–114. doi: 10.1093/toxsci/kfaa138.
   PubMed Web of Science ®Google Scholar
• Narizzano A, Bohannon M, East A, Guigni B, Quinn M. Jr. 2023. Reproductive and immune effects emerge at similar thresholds of PFHXs in deer mice. Reprod Toxicol. 120:108421. doi: 10.1016/j.reprotox.2023.108421.
   PubMed Web of Science ®Google Scholar
• Nera K-P, Kyläniemi MK, Lassila O. 2015. Regulation of B-cell to plasma cell transition within the follicular B-cell response. Scand J Immunol. 82(3):225–234. doi: 10.1111/sji.12336.
   PubMed Web of Science ®Google Scholar
• Nilsson S, Smurthwaite K, Aylward LL, Kay M, Toms LM, King L, Marrington S, Barnes C, Kirk MD, Mueller JF, et al. 2022. Serum concentration trends and apparent half-lives of per- and polyfluoroalkyl substances (PFAS) in Australian firefighters. Int J Hyg Environ Health. 246:114040. doi: 10.1016/j.ijheh.2022.114040.
   PubMed Web of Science ®Google Scholar
• Ojo A, Peng C, Ng J. 2021. Assessing the human health risks of per- and polyfluoroalkyl substances: A need for greater focus on their interactions as mixtures. J Hazard Mater. 407:124863. doi: 10.1016/j.jhazmat.2020.124863.
   PubMed Web of Science ®Google Scholar
• Peden-Adams M, Keller J, Eudaly J, Berger J, Gilkeson G, Keil D. 2008. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 104(1):144–154. doi: 10.1093/toxsci/kfn059.
   PubMed Web of Science ®Google Scholar
• Pérez F, Nadal M, Navarro-Ortega A, Fàbrega F, Domingo JL, Barceló D, Farré M. 2013. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 59:354–362. doi: 10.1016/j.envint.2013.06.004.
   PubMed Web of Science ®Google Scholar
• Post G, Louis J, Lippincott R, Procopio N. 2013. Occurrence of perfluorinated compounds in raw water from New Jersey public drinking water systems. Environ Sci Technol. 47(23):13266–13275. doi: 10.1021/es402884x.
   PubMed Web of Science ®Google Scholar
• Post C, Myers J, Winans B, Lawrence B. 2023. Postnatal administration of S-adenosylmethi-onine restores developmental Ahr activation-induced deficits in CD8+ T-cell function during influenza a virus infection. Toxicol Sci. 192(2):233–246. doi: 10.1093/toxsci/kfad019.
   PubMed Web of Science ®Google Scholar
• Rockwell C, Turley A, Cheng X, Fields P, Klaassen C. 2013. Acute immunotoxic effects of perfluorononanoic acid (PFNA) in C57Bl/6 mice. Clin Exp Pharmacol. (Suppl. 4):S4-002.
   PubMedGoogle Scholar
• Rockwell C, Turley A, Cheng X, Fields P, Klaassen C. 2017. Persistent alterations in immune cell populations and function from a single dose of perfluorononanoic acid (PFNA) in C57Bl/6 mice. Food Chem Toxicol. 100:24–33. doi: 10.1016/j.fct.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Rosato I, Bonato T, Fletcher T, Batzella E, Canova C. 2023. Estimation of per- and poly-fluoro-alkyl substances (PFAS) half-lives in human studies: A systematic review and meta-analysis. Environ Res. 242:117743. doi: 10.1016/j.envres.2023.117743.
   PubMed Web of Science ®Google Scholar
• Rosen M, Das K, Rooney J, Abbott B, Lau C, Corton J. 2017. PPARα-independent transcrip-tional targets of perfluoroalkyl acids revealed by transcript profiling. Toxicology. 387:95–107. doi: 10.1016/j.tox.2017.05.013.
   PubMed Web of Science ®Google Scholar
• Schlezinger J, Puckett H, Oliver J, Nielsen G, Heiger-Bernays W, Webster T. 2020. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an american diet. Toxicol Appl Pharmacol. 405:115204. doi: 10.1016/j.taap.2020.115204.
   PubMed Web of Science ®Google Scholar
• Smalling KL, Romanok KM, Bradley PM, Morriss MC, Gray JL, Kanagy LK, Gordon SE, Williams BM, Breitmeyer SE, Jones DK, et al. 2023. Per- and polyfluoroalkyl substances (PFAS) in United States tap water: Comparison of underserved private-well and public-supply exposures and associated health implications. Environ Int. 178:108033. doi: 10.1016/j.envint.2023.108033.
   PubMed Web of Science ®Google Scholar
• Strutt T, McKinstry K, Marshall N, Vong A, Dutton R, Swain S. 2013. Multi-pronged CD4+ T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol Rev. 255(1):149–164. doi: 10.1111/imr.12088.
   PubMed Web of Science ®Google Scholar
• Sunderland E, Hu X, Dassuncao C, Tokranov A, Wagner C, Allen J. 2019. A review of the pathways of human exposure to poly- and per-fluoroalkyl substances (PFASs) and present understanding of health effects. J Expo Sci Environ Epidemiol. 29(2):131–147. doi: 10.1038/s41370-018-0094-1.
   PubMed Web of Science ®Google Scholar
• Taylor K, Woodlief T, Ahmed A, Hu Q, Duncker P, DeWitt J. 2023. Quantifying the impact of pfoa exposure on b-cell development and antibody production. Toxicol Sci. 194(1):101–108. doi: 10.1093/toxsci/kfad043.
   PubMed Web of Science ®Google Scholar
• Torres L, Redko A, Limper C, Imbiakha B, Chang S, August A. 2021. Effect of perfluorooctane-sulfonic acid (PFOS) on immune cell development and function in mice. Immunol Lett. 233:31–41. doi: 10.1016/j.imlet.2021.03.006.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency [USEPA]. 2022. Lifetime drinking water health advisories for four perfluoroalkyl substances
   Google Scholar
• USEPA. 2023a. Framework for estimating non-cancer health risks associated with mixtures of per- and poly-fluoroalkyl substances (PFAS).
   Google Scholar
• USEPA. 2023b. Per- and poly-fluoroalkyl substances national primary drinking water regulation. EPA-HQ-OW-2022-0114-0027. 18638–18754.
   Google Scholar
• USEPA. 2023c. Public comment draft - toxicity assessment and proposed maximum contaminant level goal (MCLG) for perfluorooctane sulfonic acid (PFOS) (CASRN 1763-23-1) in drinking water.
   Google Scholar
• USEPA. 2023d. Public comment draft - toxicity assessment and proposed maximum contaminant level goal (MCLG) for perfluorooctanoic acid (PFOA) (CASRN 335-67-1) in drinking water.
   Google Scholar
• Warren T, Mitchell K, Lawrence B. 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci. 56(1):114–123. doi: 10.1093/toxsci/56.1.114.
   PubMed Web of Science ®Google Scholar
• Winans B, Nagari A, Chae M, Post C, Ko C, Puga A, Kraus W, Lawrence B. 2015. Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T-cell responses. J Immunol. 194(9):4446–4457. doi: 10.4049/jimmunol.1402044.
   PubMed Web of Science ®Google Scholar